INDIAN PHARMACEUTICAL ALLIANCE

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2020

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2020	—	2	1
2019	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MFJ INTERNATIONAL	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	5
U.S. Trade Representative (USTR)	5
Health & Human Services, Dept of (HHS)	4
SENATE	4
Centers For Medicare and Medicaid Services (CMS)	2
Federal Trade Commission (FTC)	2
Food & Drug Administration (FDA)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Trade (domestic/foreign)	Trade (domestic/foreign)	6

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 938116th Congress

BLOCKING Act of 2019

2020 · first_quarter · Firm: MFJ INTERNATIONAL

Cited source text and reported amounts

Trade related to generic medicines and biosimilars. H.R. 938, BLOCKING Act of 2019.

Client expense: — · Firm income: —

Matched citations: H.R. 938